| Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer (NCT02450656) | The Netherlands Cancer Institute | 2015-06-01 |
| Brown Adipose Tissue Activity and Energy Metabolism in Cachexia (NCT02500004) | Maastricht University Medical Center | 2015-06-01 |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia (NCT02267707) | Celgene | 2015-05-27 |
| A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours (NCT02402062) | Grupo Espanol de Tumores Neuroendocrinos | 2015-05-11 |
| Onco-geriatric Database of Patients With Pancreatic Cancer (NCT02858141) | Institut Paoli-Calmettes | 2015-05-01 |
| Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III) (NCT02460432) | Taewoong Medical Co., Ltd. | 2015-05-01 |
| Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients (NCT02400398) | Andrew Hendifar, MD | 2015-04-27 |
| Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) (NCT02301143) | Celgene | 2015-04-21 |
| The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer (NCT04406831) | Nuvance Health | 2015-04-01 |
| SBRT Pre-operatively for Pancreatic Cancer (NCT02308722) | University of Oxford | 2015-04-01 |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer (NCT02311361) | National Cancer Institute (NCI) | 2015-03-25 |
| The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery (NCT02381249) | St. James's Hospital, Ireland | 2015-03-01 |
| Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer (NCT02309177) | Celgene | 2015-01-12 |
| Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy (NCT03738787) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-01-01 |
| Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient (NCT02338752) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| Whipple Procedure: Standard of Care vs. Thunderbeat (NCT02204124) | Washington University School of Medicine | 2015-01-01 |
| The Canadian/US Integrative Oncology Study (NCT02494037) | The Canadian College of Naturopathic Medicine | 2015-01-01 |
| Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer (NCT02342847) | Celgene | 2014-12-10 |
| Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer. (NCT02292745) | Foundation for Liver Research | 2014-12-02 |
| Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC) (NCT02531607) | AdventHealth | 2014-11-13 |
| Follow-up Study of Complications of Acute Pancreatitis (NCT02305914) | The First Affiliated Hospital of Nanchang University | 2014-11-01 |
| Pancreatic Surgical Database (NCT02871336) | Institut Paoli-Calmettes | 2014-11-01 |
| A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy (NCT02270554) | Wakayama Medical University | 2014-10-01 |
| Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients (NCT02374411) | Edward Hospital | 2014-09-01 |
| Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer (NCT02220062) | Samsung Medical Center | 2014-08-01 |
| 22 G - 25 G SINS Trial for Pancreatic Masses (NCT02424838) | AdventHealth | 2014-07-28 |
| A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer (NCT02146313) | Genentech, Inc. | 2014-06-22 |
| The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery (NCT02728921) | Region Skane | 2014-04-01 |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (NCT01964430) | Celgene | 2014-03-28 |
| Feasibility of Using Ultrasound to Track Respiration Motion (NCT02173353) | Medical College of Wisconsin | 2014-02-01 |
| Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm (NCT02528526) | University of Zurich | 2014-02-01 |
| Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I (NCT01852890) | Joseph J. Cullen | 2014-01-01 |
| Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer (NCT02043288) | Orient Europharma Co., Ltd. | 2014-01-01 |
| Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer (NCT02017015) | Celgene | 2013-12-24 |
| Pancreas Volume and Diabetes Status Following Pancreatectomy (NCT02823678) | Florida Hospital Tampa Bay Division | 2013-10-01 |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma (NCT01950572) | National Cancer Institute (NCI) | 2013-09-09 |
| Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract (NCT01770405) | Mauna Kea Technologies | 2013-09-01 |
| DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer (NCT02079363) | Aalborg University Hospital | 2013-08-01 |
| Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies (NCT01677559) | Washington University School of Medicine | 2013-05-07 |
| VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors (NCT01784861) | Washington University School of Medicine | 2013-05-03 |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (NCT01832116) | University Medical Center Groningen | 2013-03-01 |
| The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent (NCT01836237) | University of Calgary | 2013-02-01 |
| Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass (NCT01727921) | Samsung Medical Center | 2013-01-01 |
| Needle-based Confocal Endomicroscopy Examination of Pancreatic Masse (NCT01734967) | Herlev Hospital | 2012-11-01 |
| Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy (NCT01731821) | Fudan University | 2012-10-01 |
| Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer (NCT01515046) | Joseph J. Cullen | 2012-09-01 |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer (NCT01313416) | Augusta University | 2012-09-01 |
| Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas (NCT01563133) | Mauna Kea Technologies | 2012-06-01 |
| FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma (NCT01413022) | Washington University School of Medicine | 2012-04-01 |
| Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy (NCT01695447) | TingBo Liang | 2012-01-01 |
| Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin (NCT01434459) | Emory University | 2011-09-01 |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma (NCT01383538) | Andrew Ko | 2011-08-23 |
| Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NCT01372735) | University Hospital Heidelberg | 2011-08-01 |
| Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy (NCT01384253) | Orano Med LLC | 2011-07-01 |
| On-site Cytopathology EUS-FNA (NCT01386931) | University of Colorado, Denver | 2011-06-01 |
| Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy (NCT01368094) | Centre Hospitalier Universitaire, Amiens | 2011-06-01 |
| SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790) | National Cancer Institute (NCI) | 2011-05-11 |
| Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy (NCT01759706) | Università Vita-Salute San Raffaele | 2010-10-01 |
| Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer (NCT01121848) | Sanofi | 2010-07-01 |
| Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision (NCT01188109) | Emory University | 2010-07-01 |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma (NCT01161186) | University of California, San Francisco | 2010-07-01 |
| A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma (NCT01166490) | Seagen Inc. | 2010-07-01 |
| Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy (NCT05616403) | Tongji Hospital | 2010-01-18 |
| Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms (NCT01057355) | Mayo Clinic | 2010-01-01 |
| The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT): (NCT04237441) | Rigshospitalet, Denmark | 2010-01-01 |
| A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer (NCT01049880) | Joseph J. Cullen | 2009-12-01 |
| A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer (NCT01019382) | University Hospitals, Leicester | 2009-10-01 |
| Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia (NCT00985777) | H. Lee Moffitt Cancer Center and Research Institute | 2009-09-01 |
| Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer (NCT00711997) | Anchiano Therapeutics Israel Ltd. | 2009-08-01 |
| Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy (NCT00915863) | Wakayama Medical University | 2009-06-01 |
| Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer (NCT01086332) | University of Iowa | 2009-05-01 |
| RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction (NCT00980889) | Stockholm South General Hospital | 2009-05-01 |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery (NCT00833859) | H. Lee Moffitt Cancer Center and Research Institute | 2009-03-01 |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors (NCT00841191) | Centocor, Inc. | 2009-03-01 |
| Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer (NCT00732082) | Washington University School of Medicine | 2009-02-01 |
| A Study for Participants With Pancreatic Cancer (NCT00839332) | Eli Lilly and Company | 2009-02-01 |
| Strength Training on Pancreatic Cancer (NCT01395563) | German Cancer Research Center | 2009-01-01 |
| Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer (NCT00813163) | PharmaEngine | 2009-01-01 |
| Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors (NCT01215578) | Assistance Publique - Hôpitaux de Paris | 2008-10-01 |
| A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer (NCT00637247) | AmpliMed Corporation | 2008-04-01 |
| CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma (NCT00634751) | University of Wisconsin, Madison | 2008-02-01 |
| A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma (NCT00558207) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2007-11-01 |
| Expression of Inflammatory Proteins in Pancreatic Cancer (NCT00551057) | University of Zurich | 2007-10-01 |
| The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma (NCT00644254) | KU Leuven | 2007-10-01 |
| Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer (NCT00529113) | Biogen | 2007-09-30 |
| Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer (NCT00515866) | AstraZeneca | 2007-08-01 |
| Reinforced Staple Line on Leak Rate in Distal Pancreatectomy (NCT01359410) | Washington University School of Medicine | 2007-06-01 |
| Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT02215044) | Boehringer Ingelheim | 2007-06-01 |
| Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer (NCT00487851) | Karolinska Institutet | 2007-03-01 |
| Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas (NCT00419627) | Hillel Yaffe Medical Center | 2007-02-01 |
| Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer (NCT00417287) | Cascadian Therapeutics Inc. | 2006-12-01 |
| Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma (NCT00495924) | KU Leuven | 2006-10-01 |
| Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors (NCT00385177) | Achieve Life Sciences | 2006-09-01 |
| Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer (NCT00710710) | Boehringer Ingelheim | 2006-08-01 |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy (NCT00363051) | Novartis Pharmaceuticals | 2006-06-01 |
| Preop Chemoradiation Resectable Pancreas (NCT00336648) | M.D. Anderson Cancer Center | 2006-06-01 |
| A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy (NCT00359320) | Thomas Jefferson University | 2006-05-25 |
| High Dose Somatostatin Analogues in Neuroendocrine Tumors (NCT00990535) | Federico II University | 2006-01-01 |
| GEMOX: Oxaliplatin in Pancreatic Cancer (NCT00261092) | Sanofi | 2005-10-01 |
| AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer (NCT00219557) | Pfizer | 2005-07-05 |